Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pieters, J.
Right arrow Articles by Willems, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pieters, J.
Right arrow Articles by Willems, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Heparin-stimulated inhibition of factor IXa generation and factor IXa neutralization in plasma

J Pieters, T Lindhout and G Willems

Department of Biochemistry, University of Limburg, Maastricht, The Netherlands.

Generation and inhibition of activated factor IXa was studied in factor XIa-activated plasma containing 4 mmol/L free calcium ions and 20 mumol/L phospholipid (25 mol% phosphatidylserine/75 mol% phosphatidylcholine). Interference of other (activated) clotting factors with the factor IXa activity measurements could be avoided by using a highly specific and sensitive bioassay. Factor IXa generation curves were analyzed according to a model that assumed Michaelis-Menten kinetics of factor XIa-catalyzed factor IXa formation and pseudo first order kinetics of inhibition of factor XIa and factor IXa. In the absence of heparin, factor IXa activity in plasma reached final levels that were found to increase with increasing amounts of factor XIa used to activate the plasma. When the model was fitted to this set of factor IXa generation curves, the analysis yielded a rate constant of inhibition of factor XIa of 0.7 +/- 0.1 min-1 and a kcat/Km ratio of 0.29 +/- 0.01 (nmol/L)-1 min-1. No neutralization of factor IXa activity was observed (the estimated rate constant of inhibition of factor IXa was 0). Thus, in the absence of heparin, the final level of factor IXa in plasma is only dependent on the initial factor XIa concentration. While neutralization of in situ generated factor IXa in normal plasma was negligible, unfractionated heparin dramatically enhanced the rate of inactivation of factor IXa (apparent second order rate constant of inhibition of 5.2 min-1/per microgram heparin/mL). The synthetic pentasaccharide heparin, the smallest heparin chain capable of binding antithrombin III, stimulated the inhibition of in situ generated factor IXa, but sevenfold less than unfractionated heparin (k = 0.76 min-1 per microgram pentasaccharide/mL). We found that free calcium ions were absolutely required to observe an unfractionated heparin and pentasaccharide-stimulated neutralization of factor IXa activity. Factor XIa inhibition (psuedo first order rate constant of 0.7 min-1) was not affected by unfractionated heparin or pentasaccharide in the range of heparin concentrations studied.

Volume 76, Issue 3, pp. 549-554, 08/01/1990
Copyright © 1990 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. Jesty and E. Beltrami
Positive Feedbacks of Coagulation: Their Role in Threshold Regulation
Arterioscler. Thromb. Vasc. Biol., December 1, 2005; 25(12): 2463 - 2469.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. M. Wiebe, A. R. Stafford, J. C. Fredenburgh, and J. I. Weitz
Mechanism of Catalysis of Inhibition of Factor IXa by Antithrombin in the Presence of Heparin or Pentasaccharide
J. Biol. Chem., September 12, 2003; 278(37): 35767 - 35774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Yang, C. Manithody, S. T. Olson, and A. R. Rezaie
Contribution of Basic Residues of the Autolysis Loop to the Substrate and Inhibitor Specificity of Factor IXa
J. Biol. Chem., June 27, 2003; 278(27): 25032 - 25038.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. D. Marmur, S. X. Anand, R. S. Bagga, J. Fareed, C.-M. Pan, S. K. Sharma, and M. F. Richard
The activated clotting time can be used to monitor the low molecular weight heparin dalteparin after intravenous administration
J. Am. Coll. Cardiol., February 5, 2003; 41(3): 394 - 402.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M.C. Minnema, D. Pajkrt, W.A. Wuillemin, D. Roem, W.K. Bleeker, M. Levi, S.J.H. van Deventer, C.E. Hack, and H. ten Cate
Activation of Clotting Factor XI Without Detectable Contact Activation in Experimental Human Endotoxemia
Blood, November 1, 1998; 92(9): 3294 - 3301.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1990 by American Society of Hematology         Online ISSN: 1528-0020